We are live on ! Find out more
ISPC icon

iSpecimen
ISPC

5 hedge funds and large institutions have $63.7K invested in iSpecimen in 2025 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 0 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

25% more funds holding

Funds holding: 4 → 5 (+1)

2.53% more ownership

Funds ownership: 3.72% → 6.26% (+2.5%)

33% less capital invested

Capital invested by funds: $94.9K → $63.7K (-$31.2K)

Holders
5
Holders Change
+1
Holders Change %
+25%
% of All Funds
0.07%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
2
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
UBS Group
UBS Group
Switzerland
+$20.4K
2
Geode Capital Management
Geode Capital Management
Massachusetts
+$20.4K
3
TRCT
Tower Research Capital (TRC)
New York
+$5.47K

Top Sellers

No sellers this quarter

ISPC Hedge Fund Activity: Q1 2025 in Review

5 of the 7,472 institutional investors tracked by Wall St. Rank reported a position in iSpecimen (ISPC) for Q1 2025, worth a combined $63.7K — down 33% from $94.9K a quarter earlier.

Buyers outnumbered sellers: 1 fund opened new ISPC positions and 0 closed out — a net gain of 1 holder — while 2 added to existing stakes and 0 trimmed.

The largest buyer was UBS Group, adding an estimated $20.4K.

  • 5 institutional investors held iSpecimen (ISPC) as of Q1 2025, up from 4 in Q4 2024.
  • Funds reported $63.7K of iSpecimen stock for Q1 2025, down 33% quarter-over-quarter.
  • 1 fund opened new iSpecimen positions in Q1 2025 and 0 closed out, a net change of +1 holder.
  • The largest iSpecimen buyer in Q1 2025 was UBS Group, an estimated $20.4K added.

Based on aggregated 13F filings for Q1 2025.